In vitro and ex vivo characterization of nanonized amniotic membrane particles: An untapped modality for ocular surface reconstruction

The pristine Human Amniotic Membrane (HAM) has portrayed outstanding potential as scaffold for ocular surface reconstruction and regeneration. However, in treatment procedures where the supporting membrane matrix of HAM is not obligatory and only the bioactive molecules are vital, the surgical pract...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Experimental eye research 2023-06, Vol.231, p.109471-109471, Article 109471
Hauptverfasser: Thada, Raja Rajeshwari, Debata, Mayadhar, Mandal, Shuvam, Gunasekaran, Deebasuganya, Mohan, Vimala Devi, Chandrasekaran, Niranjana, Sivagnanam, Uma Tiruchirapalli
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 109471
container_issue
container_start_page 109471
container_title Experimental eye research
container_volume 231
creator Thada, Raja Rajeshwari
Debata, Mayadhar
Mandal, Shuvam
Gunasekaran, Deebasuganya
Mohan, Vimala Devi
Chandrasekaran, Niranjana
Sivagnanam, Uma Tiruchirapalli
description The pristine Human Amniotic Membrane (HAM) has portrayed outstanding potential as scaffold for ocular surface reconstruction and regeneration. However, in treatment procedures where the supporting membrane matrix of HAM is not obligatory and only the bioactive molecules are vital, the surgical practise of HAM grafting causes redundant trauma and economic burden to the patient. Hence, in our laboratory we have attempted to break down HAM to nanoscale particles and validate its potential as a competent ocular therapeutic agent; by conducting a comparative analysis between the fresh, lyophilized, micronized and Nanonized Amniotic Membrane (NAM) particles. Our results evidently showcased that the prepared NAM particles was
doi_str_mv 10.1016/j.exer.2023.109471
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2805025566</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0014483523000921</els_id><sourcerecordid>2805025566</sourcerecordid><originalsourceid>FETCH-LOGICAL-c356t-a95919648c3d7bb85e36a96dfb12ffde5324d4b1862cb380c8e3e663c17ac1883</originalsourceid><addsrcrecordid>eNp9kM1u1DAUhS1ERYeBF2CBvGSTwY4Tx0FsqgpopUps2rV1Y98IjxI72M6o7QP0uevRFJZd3R-dc67uR8gnznaccfl1v8N7jLua1aIs-qbjb8imNLJijHVvyYYx3lSNEu05eZ_SvmxF0zXvyLnomJK9FBvydO3pweUYKHhL8b4Mh0DNH4hgMkb3CNkFT8NIPfjg3SNaCrN3ITtDZ5yHCB7pArHME6Zv9MLT1WdYliKcg4XJ5Qc6hkiDWSeINK1xBIM0ogk-5bia44EP5GyEKeHHl7oldz9_3F5eVTe_f11fXtxURrQyV9C3Pe9lo4yw3TCoFoWEXtpx4PU4WmxF3dhm4ErWZhCKGYUCpRSGd2C4UmJLvpxylxj-rpiynl0yOE3li7AmXSvWsrpti2dL6pPUxJBSxFEv0c0QHzRn-shf7_WRvz7y1yf-xfT5JX8dZrT_Lf-AF8H3kwDLlwdX7Mk49AatK0SytsG9lv8M2U6Zxg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2805025566</pqid></control><display><type>article</type><title>In vitro and ex vivo characterization of nanonized amniotic membrane particles: An untapped modality for ocular surface reconstruction</title><source>MEDLINE</source><source>ScienceDirect Freedom Collection (Elsevier)</source><creator>Thada, Raja Rajeshwari ; Debata, Mayadhar ; Mandal, Shuvam ; Gunasekaran, Deebasuganya ; Mohan, Vimala Devi ; Chandrasekaran, Niranjana ; Sivagnanam, Uma Tiruchirapalli</creator><creatorcontrib>Thada, Raja Rajeshwari ; Debata, Mayadhar ; Mandal, Shuvam ; Gunasekaran, Deebasuganya ; Mohan, Vimala Devi ; Chandrasekaran, Niranjana ; Sivagnanam, Uma Tiruchirapalli</creatorcontrib><description>The pristine Human Amniotic Membrane (HAM) has portrayed outstanding potential as scaffold for ocular surface reconstruction and regeneration. However, in treatment procedures where the supporting membrane matrix of HAM is not obligatory and only the bioactive molecules are vital, the surgical practise of HAM grafting causes redundant trauma and economic burden to the patient. Hence, in our laboratory we have attempted to break down HAM to nanoscale particles and validate its potential as a competent ocular therapeutic agent; by conducting a comparative analysis between the fresh, lyophilized, micronized and Nanonized Amniotic Membrane (NAM) particles. Our results evidently showcased that the prepared NAM particles was &lt;100 nm and the major biomolecules such as collagen and hyaluronic acid were well retained. Further, the NAM particles eluted significantly higher amounts of proteins and growth factors while maintaining its stability and isotonicity when stored at 4 °C. Its biostability was assayed in the presence of lysozyme enzyme. Its remarkable ability to promote cell proliferation in rabbit corneal cells and negative cytotoxicity is an added advantage for ocular application. The ocular biocompatibility of NAM, evaluated by the ex vivo assessment of corneal thickness, transparency, histopathology, immunohistochemistry and corneal permeability clearly indicated its suitability for ophthalmic applications. [Display omitted] •The prepared Nanonized Amniotic Membrane (NAM) particles reported an average size of 75 nm.•The total collagen, collagen type I and IV were well retained; while hyaluronic acid was significantly elevated in NAM.•The NAM particles eluted higher amounts of proteins and growth factors when compared to pristine amniotic membrane.•The in vitro analyses of NAM displayed good biocompatibility and cell proliferating capabilities.•The ex vivo experiments demonstrated the ability of NAM to serve as an improved therapeutic agent for ocular treatments.</description><identifier>ISSN: 0014-4835</identifier><identifier>EISSN: 1096-0007</identifier><identifier>DOI: 10.1016/j.exer.2023.109471</identifier><identifier>PMID: 37086963</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Amnion ; Animals ; Collagen ; Cornea ; Cryomilling ; Ex vivo study ; Growth factors ; Human amniotic membrane ; Humans ; Microarray ; Nanonization ; Rabbits</subject><ispartof>Experimental eye research, 2023-06, Vol.231, p.109471-109471, Article 109471</ispartof><rights>2023 Elsevier Ltd</rights><rights>Copyright © 2023 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c356t-a95919648c3d7bb85e36a96dfb12ffde5324d4b1862cb380c8e3e663c17ac1883</citedby><cites>FETCH-LOGICAL-c356t-a95919648c3d7bb85e36a96dfb12ffde5324d4b1862cb380c8e3e663c17ac1883</cites><orcidid>0000-0002-1401-2569</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.exer.2023.109471$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37086963$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Thada, Raja Rajeshwari</creatorcontrib><creatorcontrib>Debata, Mayadhar</creatorcontrib><creatorcontrib>Mandal, Shuvam</creatorcontrib><creatorcontrib>Gunasekaran, Deebasuganya</creatorcontrib><creatorcontrib>Mohan, Vimala Devi</creatorcontrib><creatorcontrib>Chandrasekaran, Niranjana</creatorcontrib><creatorcontrib>Sivagnanam, Uma Tiruchirapalli</creatorcontrib><title>In vitro and ex vivo characterization of nanonized amniotic membrane particles: An untapped modality for ocular surface reconstruction</title><title>Experimental eye research</title><addtitle>Exp Eye Res</addtitle><description>The pristine Human Amniotic Membrane (HAM) has portrayed outstanding potential as scaffold for ocular surface reconstruction and regeneration. However, in treatment procedures where the supporting membrane matrix of HAM is not obligatory and only the bioactive molecules are vital, the surgical practise of HAM grafting causes redundant trauma and economic burden to the patient. Hence, in our laboratory we have attempted to break down HAM to nanoscale particles and validate its potential as a competent ocular therapeutic agent; by conducting a comparative analysis between the fresh, lyophilized, micronized and Nanonized Amniotic Membrane (NAM) particles. Our results evidently showcased that the prepared NAM particles was &lt;100 nm and the major biomolecules such as collagen and hyaluronic acid were well retained. Further, the NAM particles eluted significantly higher amounts of proteins and growth factors while maintaining its stability and isotonicity when stored at 4 °C. Its biostability was assayed in the presence of lysozyme enzyme. Its remarkable ability to promote cell proliferation in rabbit corneal cells and negative cytotoxicity is an added advantage for ocular application. The ocular biocompatibility of NAM, evaluated by the ex vivo assessment of corneal thickness, transparency, histopathology, immunohistochemistry and corneal permeability clearly indicated its suitability for ophthalmic applications. [Display omitted] •The prepared Nanonized Amniotic Membrane (NAM) particles reported an average size of 75 nm.•The total collagen, collagen type I and IV were well retained; while hyaluronic acid was significantly elevated in NAM.•The NAM particles eluted higher amounts of proteins and growth factors when compared to pristine amniotic membrane.•The in vitro analyses of NAM displayed good biocompatibility and cell proliferating capabilities.•The ex vivo experiments demonstrated the ability of NAM to serve as an improved therapeutic agent for ocular treatments.</description><subject>Amnion</subject><subject>Animals</subject><subject>Collagen</subject><subject>Cornea</subject><subject>Cryomilling</subject><subject>Ex vivo study</subject><subject>Growth factors</subject><subject>Human amniotic membrane</subject><subject>Humans</subject><subject>Microarray</subject><subject>Nanonization</subject><subject>Rabbits</subject><issn>0014-4835</issn><issn>1096-0007</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kM1u1DAUhS1ERYeBF2CBvGSTwY4Tx0FsqgpopUps2rV1Y98IjxI72M6o7QP0uevRFJZd3R-dc67uR8gnznaccfl1v8N7jLua1aIs-qbjb8imNLJijHVvyYYx3lSNEu05eZ_SvmxF0zXvyLnomJK9FBvydO3pweUYKHhL8b4Mh0DNH4hgMkb3CNkFT8NIPfjg3SNaCrN3ITtDZ5yHCB7pArHME6Zv9MLT1WdYliKcg4XJ5Qc6hkiDWSeINK1xBIM0ogk-5bia44EP5GyEKeHHl7oldz9_3F5eVTe_f11fXtxURrQyV9C3Pe9lo4yw3TCoFoWEXtpx4PU4WmxF3dhm4ErWZhCKGYUCpRSGd2C4UmJLvpxylxj-rpiynl0yOE3li7AmXSvWsrpti2dL6pPUxJBSxFEv0c0QHzRn-shf7_WRvz7y1yf-xfT5JX8dZrT_Lf-AF8H3kwDLlwdX7Mk49AatK0SytsG9lv8M2U6Zxg</recordid><startdate>202306</startdate><enddate>202306</enddate><creator>Thada, Raja Rajeshwari</creator><creator>Debata, Mayadhar</creator><creator>Mandal, Shuvam</creator><creator>Gunasekaran, Deebasuganya</creator><creator>Mohan, Vimala Devi</creator><creator>Chandrasekaran, Niranjana</creator><creator>Sivagnanam, Uma Tiruchirapalli</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-1401-2569</orcidid></search><sort><creationdate>202306</creationdate><title>In vitro and ex vivo characterization of nanonized amniotic membrane particles: An untapped modality for ocular surface reconstruction</title><author>Thada, Raja Rajeshwari ; Debata, Mayadhar ; Mandal, Shuvam ; Gunasekaran, Deebasuganya ; Mohan, Vimala Devi ; Chandrasekaran, Niranjana ; Sivagnanam, Uma Tiruchirapalli</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c356t-a95919648c3d7bb85e36a96dfb12ffde5324d4b1862cb380c8e3e663c17ac1883</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Amnion</topic><topic>Animals</topic><topic>Collagen</topic><topic>Cornea</topic><topic>Cryomilling</topic><topic>Ex vivo study</topic><topic>Growth factors</topic><topic>Human amniotic membrane</topic><topic>Humans</topic><topic>Microarray</topic><topic>Nanonization</topic><topic>Rabbits</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Thada, Raja Rajeshwari</creatorcontrib><creatorcontrib>Debata, Mayadhar</creatorcontrib><creatorcontrib>Mandal, Shuvam</creatorcontrib><creatorcontrib>Gunasekaran, Deebasuganya</creatorcontrib><creatorcontrib>Mohan, Vimala Devi</creatorcontrib><creatorcontrib>Chandrasekaran, Niranjana</creatorcontrib><creatorcontrib>Sivagnanam, Uma Tiruchirapalli</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Experimental eye research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Thada, Raja Rajeshwari</au><au>Debata, Mayadhar</au><au>Mandal, Shuvam</au><au>Gunasekaran, Deebasuganya</au><au>Mohan, Vimala Devi</au><au>Chandrasekaran, Niranjana</au><au>Sivagnanam, Uma Tiruchirapalli</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>In vitro and ex vivo characterization of nanonized amniotic membrane particles: An untapped modality for ocular surface reconstruction</atitle><jtitle>Experimental eye research</jtitle><addtitle>Exp Eye Res</addtitle><date>2023-06</date><risdate>2023</risdate><volume>231</volume><spage>109471</spage><epage>109471</epage><pages>109471-109471</pages><artnum>109471</artnum><issn>0014-4835</issn><eissn>1096-0007</eissn><abstract>The pristine Human Amniotic Membrane (HAM) has portrayed outstanding potential as scaffold for ocular surface reconstruction and regeneration. However, in treatment procedures where the supporting membrane matrix of HAM is not obligatory and only the bioactive molecules are vital, the surgical practise of HAM grafting causes redundant trauma and economic burden to the patient. Hence, in our laboratory we have attempted to break down HAM to nanoscale particles and validate its potential as a competent ocular therapeutic agent; by conducting a comparative analysis between the fresh, lyophilized, micronized and Nanonized Amniotic Membrane (NAM) particles. Our results evidently showcased that the prepared NAM particles was &lt;100 nm and the major biomolecules such as collagen and hyaluronic acid were well retained. Further, the NAM particles eluted significantly higher amounts of proteins and growth factors while maintaining its stability and isotonicity when stored at 4 °C. Its biostability was assayed in the presence of lysozyme enzyme. Its remarkable ability to promote cell proliferation in rabbit corneal cells and negative cytotoxicity is an added advantage for ocular application. The ocular biocompatibility of NAM, evaluated by the ex vivo assessment of corneal thickness, transparency, histopathology, immunohistochemistry and corneal permeability clearly indicated its suitability for ophthalmic applications. [Display omitted] •The prepared Nanonized Amniotic Membrane (NAM) particles reported an average size of 75 nm.•The total collagen, collagen type I and IV were well retained; while hyaluronic acid was significantly elevated in NAM.•The NAM particles eluted higher amounts of proteins and growth factors when compared to pristine amniotic membrane.•The in vitro analyses of NAM displayed good biocompatibility and cell proliferating capabilities.•The ex vivo experiments demonstrated the ability of NAM to serve as an improved therapeutic agent for ocular treatments.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>37086963</pmid><doi>10.1016/j.exer.2023.109471</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0002-1401-2569</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0014-4835
ispartof Experimental eye research, 2023-06, Vol.231, p.109471-109471, Article 109471
issn 0014-4835
1096-0007
language eng
recordid cdi_proquest_miscellaneous_2805025566
source MEDLINE; ScienceDirect Freedom Collection (Elsevier)
subjects Amnion
Animals
Collagen
Cornea
Cryomilling
Ex vivo study
Growth factors
Human amniotic membrane
Humans
Microarray
Nanonization
Rabbits
title In vitro and ex vivo characterization of nanonized amniotic membrane particles: An untapped modality for ocular surface reconstruction
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T08%3A32%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=In%20vitro%20and%20ex%20vivo%20characterization%20of%20nanonized%20amniotic%20membrane%20particles:%20An%20untapped%20modality%20for%20ocular%20surface%20reconstruction&rft.jtitle=Experimental%20eye%20research&rft.au=Thada,%20Raja%20Rajeshwari&rft.date=2023-06&rft.volume=231&rft.spage=109471&rft.epage=109471&rft.pages=109471-109471&rft.artnum=109471&rft.issn=0014-4835&rft.eissn=1096-0007&rft_id=info:doi/10.1016/j.exer.2023.109471&rft_dat=%3Cproquest_cross%3E2805025566%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2805025566&rft_id=info:pmid/37086963&rft_els_id=S0014483523000921&rfr_iscdi=true